FDA
label_change
· 2013-11-27
FDA Approved: TRUVADA — Supplemental Application (Gilead Sciences, Inc)
Summary
FDA approved a supplemental application for TRUVADA (emtricitabine and tenofovir disoproxil fumarate) submitted by Gilead, indicating a change to the product la…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)